United States:
Managing ANDA Venue Issues As Del. And NJ Filings Rise
18 December 2023
WilmerHale
To print this article, all you need is to be registered or login on Mondaq.com.
In 2023, pharmaceutical patent owners filed nearly 250
infringement complaints against generic drug manufacturers. More
than 90% of those cases were filed in the Districts of Delaware or
New Jersey.
Click here to
continue reading . . .
Originally published Law360 on 1 December, 2023
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
"Patent Marking Regarding Software Medical Devices"
Marshall, Gerstein & Borun LLP
The IPO Law Journal recently published a paper titled "Patent Marking Regarding Software Medical Devices." The paper discusses an overview of patent marking-related case law...